First-line regimens with endocrine therapy show benefits in breast cancer
by Lori SolomonFirst-line regimens with endocrine therapy (ET) may be associated with benefits among patients with human epidermal growth factor receptor 2-positive (ERBB2-positive [formerly HER2-posi
Updated on: February 03,2024
19
First-line regimens with endocrine therapy show benefits in breast cancer
by Lori SolomonFirst-line regimens with endocrine therapy (ET) may be associated with benefits among patients with human epidermal growth factor receptor 2-positive (ERBB2-positive [formerly HER2-posi
Updated on:February 03,2024
19
